University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Paediatrics (RCH)
  • Paediatrics (RCH) - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Paediatrics (RCH)
  • Paediatrics (RCH) - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    Effect of rapamycin on bone mass and strength in the alpha 2(I)-G610C mouse model of osteogenesis imperfecta

    Thumbnail
    Download
    Published version (736.0Kb)

    Citations
    Scopus
    Web of Science
    Altmetric
    5
    5
    Author
    Bateman, JF; Sampurno, L; Maurizi, A; Lamande, SR; Sims, NA; Cheng, TL; Schindeler, A; Little, DG
    Date
    2019-03-01
    Source Title
    Journal of Cellular and Molecular Medicine
    Publisher
    WILEY
    University of Melbourne Author/s
    Bateman, John; Sims, Natalie; Lamande, Shireen
    Affiliation
    Paediatrics (RCH)
    Medicine and Radiology
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Bateman, J. F., Sampurno, L., Maurizi, A., Lamande, S. R., Sims, N. A., Cheng, T. L., Schindeler, A. & Little, D. G. (2019). Effect of rapamycin on bone mass and strength in the alpha 2(I)-G610C mouse model of osteogenesis imperfecta. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 23 (3), pp.1735-1745. https://doi.org/10.1111/jcmm.14072.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/253659
    DOI
    10.1111/jcmm.14072
    Abstract
    Osteogenesis imperfecta (OI) is commonly caused by heterozygous type I collagen structural mutations that disturb triple helix folding and integrity. This mutant-containing misfolded collagen accumulates in the endoplasmic reticulum (ER) and induces a form of ER stress associated with negative effects on osteoblast differentiation and maturation. Therapeutic induction of autophagy to degrade the mutant collagens could therefore be useful in ameliorating the ER stress and deleterious downstream consequences. To test this, we treated a mouse model of mild to moderate OI (α2(I) G610C) with dietary rapamycin from 3 to 8 weeks of age and effects on bone mass and mechanical properties were determined. OI bone mass and mechanics were, as previously reported, compromised compared to WT. While rapamycin treatment improved the trabecular parameters of WT and OI bones, the biomechanical deficits of OI bones were not rescued. Importantly, we show that rapamycin treatment suppressed the longitudinal and transverse growth of OI, but not WT, long bones. Our work demonstrates that dietary rapamycin offers no clinical benefit in this OI model and furthermore, the impact of rapamycin on OI bone growth could exacerbate the clinical consequences during periods of active bone growth in patients with OI caused by collagen misfolding mutations.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [53039]
    • Medicine and Radiology - Research Publications [3320]
    • Paediatrics (RCH) - Research Publications [2390]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors